Anticholinergic Burden, Sleep Quality and Health Outcomes in Malaysian Aged Care Home Residents

Suresh Kumar, Syed Shahzad Hasan, Pei Se Wong, David Weng Kwai Chong, Therese Kairuz

Research output: Contribution to journalArticle

Abstract

The use of anticholinergic medications by residents in aged care homes is associated with increased risk of adverse effects. These include cognitive impairment, sleep disturbances, and falls, and necessitate increased healthcare visits and the associated burden on healthcare systems. The objective of this study was to investigate associations between anticholinergic burden and health outcomes such as independence in activities for daily living, frailty, quality of life, and sleep quality. The study was conducted among residents in Malaysian aged care homes, aged 60 years and above. Anticholinergic burden was calculated using the Anticholinergic Cognitive Burden (ACB) scale. Health outcome measures included independence, assessed using the Katz Activities for Daily Living scale (Katz ADL); quality of life, assessed using the Older People's Quality of Life Questionnaire (OPQOL); frailty, assessed using the Groningen Frailty Index (GFI); and sleep quality, measured using the Pittsburg Sleep Quality Index (PSQI). Just over one-third (36%) of the study population was exposed to at least one medication with anticholinergic effect. An increased anticholinergic cognitive burden was associated with frailty (p = 0.031), sleep latency (p = 0.007), and sleep disturbances (p = 0.015). Further studies are required to assess the effect of prolonged exposure to anticholinergic medications on health outcomes.

Original languageEnglish
Article number143
Number of pages10
JournalPharmacy (Basel, Switzerland)
Volume7
Issue number4
DOIs
Publication statusPublished - 23 Oct 2019

Fingerprint

Homes for the Aged
Cholinergic Antagonists
Home Care Services
Sleep
Health
Quality of Life
Activities of Daily Living
Delivery of Health Care
Outcome Assessment (Health Care)

Cite this

Kumar, Suresh ; Hasan, Syed Shahzad ; Wong, Pei Se ; Chong, David Weng Kwai ; Kairuz, Therese. / Anticholinergic Burden, Sleep Quality and Health Outcomes in Malaysian Aged Care Home Residents. In: Pharmacy (Basel, Switzerland). 2019 ; Vol. 7, No. 4.
@article{0ec60014b0ea4580b5de5ff82a641ccc,
title = "Anticholinergic Burden, Sleep Quality and Health Outcomes in Malaysian Aged Care Home Residents",
abstract = "The use of anticholinergic medications by residents in aged care homes is associated with increased risk of adverse effects. These include cognitive impairment, sleep disturbances, and falls, and necessitate increased healthcare visits and the associated burden on healthcare systems. The objective of this study was to investigate associations between anticholinergic burden and health outcomes such as independence in activities for daily living, frailty, quality of life, and sleep quality. The study was conducted among residents in Malaysian aged care homes, aged 60 years and above. Anticholinergic burden was calculated using the Anticholinergic Cognitive Burden (ACB) scale. Health outcome measures included independence, assessed using the Katz Activities for Daily Living scale (Katz ADL); quality of life, assessed using the Older People's Quality of Life Questionnaire (OPQOL); frailty, assessed using the Groningen Frailty Index (GFI); and sleep quality, measured using the Pittsburg Sleep Quality Index (PSQI). Just over one-third (36{\%}) of the study population was exposed to at least one medication with anticholinergic effect. An increased anticholinergic cognitive burden was associated with frailty (p = 0.031), sleep latency (p = 0.007), and sleep disturbances (p = 0.015). Further studies are required to assess the effect of prolonged exposure to anticholinergic medications on health outcomes.",
keywords = "anticholinergics, ADL, frailty, quality of life, sleep, aged homes",
author = "Suresh Kumar and Hasan, {Syed Shahzad} and Wong, {Pei Se} and Chong, {David Weng Kwai} and Therese Kairuz",
note = "Special Issue",
year = "2019",
month = "10",
day = "23",
doi = "10.3390/pharmacy7040143",
language = "English",
volume = "7",
journal = "Pharmacy (Basel, Switzerland)",
issn = "2226-4787",
number = "4",

}

Anticholinergic Burden, Sleep Quality and Health Outcomes in Malaysian Aged Care Home Residents. / Kumar, Suresh; Hasan, Syed Shahzad; Wong, Pei Se; Chong, David Weng Kwai; Kairuz, Therese.

In: Pharmacy (Basel, Switzerland), Vol. 7, No. 4, 143, 23.10.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anticholinergic Burden, Sleep Quality and Health Outcomes in Malaysian Aged Care Home Residents

AU - Kumar, Suresh

AU - Hasan, Syed Shahzad

AU - Wong, Pei Se

AU - Chong, David Weng Kwai

AU - Kairuz, Therese

N1 - Special Issue

PY - 2019/10/23

Y1 - 2019/10/23

N2 - The use of anticholinergic medications by residents in aged care homes is associated with increased risk of adverse effects. These include cognitive impairment, sleep disturbances, and falls, and necessitate increased healthcare visits and the associated burden on healthcare systems. The objective of this study was to investigate associations between anticholinergic burden and health outcomes such as independence in activities for daily living, frailty, quality of life, and sleep quality. The study was conducted among residents in Malaysian aged care homes, aged 60 years and above. Anticholinergic burden was calculated using the Anticholinergic Cognitive Burden (ACB) scale. Health outcome measures included independence, assessed using the Katz Activities for Daily Living scale (Katz ADL); quality of life, assessed using the Older People's Quality of Life Questionnaire (OPQOL); frailty, assessed using the Groningen Frailty Index (GFI); and sleep quality, measured using the Pittsburg Sleep Quality Index (PSQI). Just over one-third (36%) of the study population was exposed to at least one medication with anticholinergic effect. An increased anticholinergic cognitive burden was associated with frailty (p = 0.031), sleep latency (p = 0.007), and sleep disturbances (p = 0.015). Further studies are required to assess the effect of prolonged exposure to anticholinergic medications on health outcomes.

AB - The use of anticholinergic medications by residents in aged care homes is associated with increased risk of adverse effects. These include cognitive impairment, sleep disturbances, and falls, and necessitate increased healthcare visits and the associated burden on healthcare systems. The objective of this study was to investigate associations between anticholinergic burden and health outcomes such as independence in activities for daily living, frailty, quality of life, and sleep quality. The study was conducted among residents in Malaysian aged care homes, aged 60 years and above. Anticholinergic burden was calculated using the Anticholinergic Cognitive Burden (ACB) scale. Health outcome measures included independence, assessed using the Katz Activities for Daily Living scale (Katz ADL); quality of life, assessed using the Older People's Quality of Life Questionnaire (OPQOL); frailty, assessed using the Groningen Frailty Index (GFI); and sleep quality, measured using the Pittsburg Sleep Quality Index (PSQI). Just over one-third (36%) of the study population was exposed to at least one medication with anticholinergic effect. An increased anticholinergic cognitive burden was associated with frailty (p = 0.031), sleep latency (p = 0.007), and sleep disturbances (p = 0.015). Further studies are required to assess the effect of prolonged exposure to anticholinergic medications on health outcomes.

KW - anticholinergics

KW - ADL

KW - frailty

KW - quality of life

KW - sleep

KW - aged homes

U2 - 10.3390/pharmacy7040143

DO - 10.3390/pharmacy7040143

M3 - Article

VL - 7

JO - Pharmacy (Basel, Switzerland)

JF - Pharmacy (Basel, Switzerland)

SN - 2226-4787

IS - 4

M1 - 143

ER -